genedrive

genedrive is a Manchester-based diagnostics company specialising in pharmacogenetic testing to support safer, more effective prescribing in acute and emergency care.

Its CE-marked and NICE-recommended technologies help prevent serious illness before it happens, cutting NHS waiting lists, improving patient outcomes and saving the system money.
The company’s rapid point-of-care tests enable clinicians to access actionable genetic information within minutes, helping to prevent avoidable harm, such as recurrent stroke and antibiotic-induced hearing loss in newborns.

These solutions are already in routine clinical use and offer significantly better patient outcomes whilst truly enabling productivity and financial gains for pressured healthcare systems.

genedrive is expanding into laboratory-based pharmacogenetic testing, enabling use in both acute and planned care pathways. This integrated lab-to-point-of-care approach allows testing to be delivered in the most clinically appropriate setting, supporting wider adoption across specialties such as cardiology and routine prescribing.

Developed with NHS partners, genedrive proudly furthers the prevention agenda, solving real-world challenges for the NHS and delivering for patients.